A patient with acromegaly who showed remarkable improvement of hyperglycemia after treatment with octreotide

10Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

A case with diabetes mellitus associated with growth hormone (GH)- producing pituitary adenoma is described. A 56-year-old woman who had been treated for diabetes mellitus for 3 years, was admitted for the treatment of hyperglycemia. She showed a few acromegalic features and her plasma GH level was 146 ±16 ng/ml. After improvement of plasma glucose level by insulin rejection, octreotide therapy (100 μg/8 hours) was started. Seven days after the initiation of octreotide therapy, the fasting plasma glucose level was almost normalized without insulin injection. After the octreotide treatment, urinary C-peptide excretion was significantly decreased and the plasma GH level became within normal range. In this case, octreotide appears to have improved the insulin sensitivity by reducing the plasma GH level.

Cite

CITATION STYLE

APA

Hirose, T., Kuroda, T., Otsuki, M., Takagi, M., Yamamoto, H., Motomura, T., … Kasayama, S. (1997). A patient with acromegaly who showed remarkable improvement of hyperglycemia after treatment with octreotide. Internal Medicine, 36(5), 345–350. https://doi.org/10.2169/internalmedicine.36.345

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free